RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus

New FDA Program to Accelerate Coronavirus Treatments

31 March 2020 | By Michael Mezher 

The US Food and Drug Administration (FDA) on Tuesday detailed a new “special emergency program” for accelerating research and develo...

Regulatory Exchange